Cours Vital Therapies Inc Nasdaq
Actions
US92847R1041
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 110 M 100 M |
---|---|---|---|---|---|
Résultat net 2024 * | -93 M -84,9 M | Résultat net 2025 * | -104 M -94,94 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | 33,12 M 30,24 M | Dette nette 2025 * | 55,55 M 50,71 M | VE / CA 2025 * | - |
PER 2024 * |
-1,23
x | PER 2025 * |
-1,23
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 92,28% |
Dernier transcript sur Vital Therapies Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 01/01/17 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 01/12/19 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/01/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19/11/19 |
Tamar Howson
BRD | Director/Board Member | 75 | 11/10/19 |
Jörg Neermann
BRD | Director/Board Member | 57 | 01/04/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,73 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |